U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796660) titled 'Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients' on Jan. 22.
Brief Summary: This study is a prospective randomized controlled trial, enrolling 60 patients with CKD stages 2-4, randomly divided into a control group and a treatment group, with 30 cases in each group. The study subjects are sourced from three centers. The control group receives integrated basic treatment for chronic kidney disease, including dietary nutrition adjustment, blood pressure control, blood sugar control, lipid control, anemia treatment, and regulation of water, electrolyte, and acid-base metabolic balance. The treatment g...